Welcome to PsychiatryAI.com: [PubMed] - Psychiatry AI Latest

Lecanemab and Donanemab as Therapies for Alzheimer’s Disease: An Illustrated Perspective on the Data

Evidence

eNeuro. 2024 Jul 1;11(7):ENEURO.0319-23.2024. doi: 10.1523/ENEURO.0319-23.2024. Print 2024 Jul.

NO ABSTRACT

PMID:38951040 | DOI:10.1523/ENEURO.0319-23.2024

Document this CPD Copy URL Button

Google

Google Keep

LinkedIn Share Share on Linkedin

Estimated reading time: 1 minute(s)

Latest: Psychiatryai.com #RAISR4D Evidence

Cool Evidence: Engaging Young People and Students in Real-World Evidence

Real-Time Evidence Search [Psychiatry]

AI Research

Lecanemab and Donanemab as Therapies for Alzheimer’s Disease: An Illustrated Perspective on the Data

Copy WordPress Title

🌐 90 Days

Evidence Blueprint

Lecanemab and Donanemab as Therapies for Alzheimer’s Disease: An Illustrated Perspective on the Data

QR Code

☊ AI-Driven Related Evidence Nodes

(recent articles with at least 5 words in title)

More Evidence

Lecanemab and Donanemab as Therapies for Alzheimer’s Disease: An Illustrated Perspective on the Data

🌐 365 Days

Floating Tab
close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI RAISR 4D System Psychiatry + Mental Health